Home

Articles from Bay Area Lyme Foundation

New Bay Area Lyme Foundation Study Reports That Only One-Third of Early Lyme Patients with On-Going Symptoms Followed up with their Healthcare Providers
The new research, published in Frontiers in Medicine, points to the need for greater follow-up from medical professionals to address potential treatment failures.
By Bay Area Lyme Foundation · Via GlobeNewswire · July 10, 2025
Bay Area Lyme Foundation Announces New Executive Director Josh Wein
Wein brings valuable life sciences and fundraising experience to advance BAL's mission
By Bay Area Lyme Foundation · Via GlobeNewswire · June 18, 2025
Twin Cities Lyme Foundation and Bay Area Lyme Foundation Unite Efforts to Further Advance the Fight Against Tick-Borne Diseases
Twin Cities Lyme Foundation Founder Lisa Najarian and her husband Former CNBC Correspondent Peter Najarian to join the Advisory Board of Bay Area Lyme Foundation
By Bay Area Lyme Foundation · Via GlobeNewswire · May 29, 2024
Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test
Winner Chao Wang of Arizona State University will receive $150,000 to evaluate a unique diagnostic that uses gold nanoparticles and has been proven in other infectious diseases
By Bay Area Lyme Foundation · Via GlobeNewswire · June 12, 2025
New Discovery Identifies “Don’t Eat Me” Protein that Allows Lyme Bacteria to Evade Body’s Immune Response
Stanford University/MIT/UCSF study funded by Bay Area Lyme Foundation offers new direction for tick-borne disease research, paving the way for potential new discoveries
Science Translational Medicine Study Funded by the Bay Area Lyme Foundation Identifies FDA-approved Piperacillin as More Effective, Targeted Treatment for Lyme Disease
An additional Science Translational Medicine study also funded by Bay Area Lyme Foundation uncovers how lingering bacterial cell wall molecules may contribute to chronic Lyme symptoms
By Bay Area Lyme Foundation · Via GlobeNewswire · April 23, 2025
UPDATE - New Study Reveals Potential Treatment for Neurological Lyme Disease
Blocking certain fibroblast growth factor receptors is shown to be effective in reducing inflammation and cell death caused by neurological Lyme infection in laboratory studies
By Bay Area Lyme Foundation · Via GlobeNewswire · April 19, 2024
Bay Area Lyme Foundation Selects National Winner of the 2024 Emerging Leader Award for Research of Combination Therapies to Treat Chronic Lyme Disease
Winner Trever Smith, of Tufts University, will collect novel therapeutic data to develop a first-of-its-kind drug interaction compendium for Lyme Disease
By Bay Area Lyme Foundation · Via GlobeNewswire · August 1, 2024
New Study Reveals Potential Treatment for Neurological Lyme Disease
Blocking certain fibroblast growth factor receptors is shown to be effective in reducing inflammation and cell death caused by neurological Lyme infection in laboratory studies
By Bay Area Lyme Foundation · Via GlobeNewswire · April 18, 2024
Combination Antibiotic Therapies May Be Capable of Eradicating Lyme Disease, According to Investigational Study Funded by Bay Area Lyme Foundation
Study identifies persistent Lyme bacteria in tissue samples and points to need for clinical studies of combination antibiotics in persistent Lyme
By Bay Area Lyme Foundation · Via GlobeNewswire · November 21, 2023
Bay Area Lyme Foundation Now Accepting Applications for 2024 Emerging Leader Award and Grant
Annual grant seeks to attract innovative researchers with a new approach for diagnosing and treating tick-borne diseases
By Bay Area Lyme Foundation · Via GlobeNewswire · October 26, 2023
Research Funded by Bay Area Lyme Foundation Identifies New Investigational Therapy Regimen Capable of Irreversibly Damaging Lyme Bacteria in Laboratory Tests
Inspired by research that targets cancer tumors, these new findings in Lyme could also lead to novel R&D strategies for other diseases
By Bay Area Lyme Foundation · Via GlobeNewswire · November 1, 2023
Bay Area Lyme Foundation ELA Winner Uses Metabolic Modeling to Predict 77 Unique Drug Targets in Lyme Disease Bacterium
Results will help inform future research and development of new Lyme disease therapeutics
By Bay Area Lyme Foundation · Via GlobeNewswire · October 19, 2023
Research funded by Bay Area Lyme Foundation provides most comprehensive and geographically widespread whole genome sequencing of Lyme bacteria
Results may help inform future research and how physicians treat Lyme disease
By Bay Area Lyme Foundation · Via GlobeNewswire · August 31, 2023
Bay Area Lyme Foundation Celebrates Its 10th Anniversary with a Convergence of Scientists, Clinicians, Patients and Celebrity Talent
BAL honors the 2023 Younger Family Emerging Leader Award Winner, announces iHeartRadio partnership and acknowledges the perseverance of patients with persistent Lyme disease
By Bay Area Lyme Foundation · Via GlobeNewswire · June 13, 2023
Bay Area Lyme Foundation Celebrates Department of Defense CDMRP Tick-borne Disease Awardees
Projects of three awardees to be enabled by Lyme Disease Biobank samples
By Bay Area Lyme Foundation · Via GlobeNewswire · March 23, 2023
National Lyme Clinical Trials Network Gains Its First West Coast Center, Thanks to $1M+ Donation from Bay Area Lyme Foundation
The University of California San Francisco Lyme Clinical Trials Center will support innovative clinical trials to develop treatments for patients with persistent Lyme disease
By Bay Area Lyme Foundation · Via GlobeNewswire · March 9, 2023
Bay Area Lyme Foundation Researcher Validates New Approach to Overcome Challenges of Lyme Disease Diagnosis in the Lab
Using samples from the Lyme Disease Biobank, Raman spectroscopy is identified as a potentially more sensitive test for diagnosing Lyme disease
By Bay Area Lyme Foundation · Via GlobeNewswire · February 6, 2023